Upturn unsubscribed user
$1.14/ day, billed weekly
Cancel anytime
(Ad-Free, Unlimited access)​
NO CREDIT CARD REQUIRED
MOVE logo MOVE
Upturn stock ratingUpturn stock rating
MOVE logo

Movano Inc (MOVE)

Upturn stock ratingUpturn stock rating
$1.4
Delayed price
upturn advisory
PASS
  • BUY Advisory
  • SELL Advisory (Profit)​
  • SELL Advisory (Loss)​
  • Profit
  • Loss
  • Pass (Skip investing)
Upturn Stock infoUpturn Stock info Stock price based on last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • YEAR
  • MONTH
  • WEEK

Upturn Advisory Summary

04/01/2025: MOVE (1-star) is currently NOT-A-BUY. Pass it for now.

Upturn Star Rating

ratingratingratingratingrating

Not Recommended Performance

These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.

AI Based Fundamental Rating

ratingratingratingratingrating

Not Recommended Performance

These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.

Analysis of Past Performance

Type Stock
Historic Profit -28.95%
Avg. Invested days 36
Today’s Advisory PASS
Upturn Star Rating Upturn stock ratingUpturn stock rating
Upturn Advisory Performance Upturn Advisory Performance 1.0
Stock Returns Performance Upturn Returns Performance 1.0
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
Upturn Profits based on simulationUpturn Profits based on simulation Last Close 04/01/2025

Key Highlights

Company Size Small-Cap Stock
Market Capitalization 27.72M USD
Price to earnings Ratio -
1Y Target Price 30
Price to earnings Ratio -
1Y Target Price 30
Volume (30-day avg) 21755
Beta 0.19
52 Weeks Range 1.16 - 8.85
Updated Date 03/30/2025
52 Weeks Range 1.16 - 8.85
Updated Date 03/30/2025
Dividends yield (FY) -
Basic EPS (TTM) -5.8

Earnings Date

Report Date -
When -
Estimate -
Actual -

Profitability

Profit Margin -
Operating Margin (TTM) -3198.83%

Management Effectiveness

Return on Assets (TTM) -88.72%
Return on Equity (TTM) -181.25%

Valuation

Trailing PE -
Forward PE -
Enterprise Value -1883085
Price to Sales(TTM) 10.3
Enterprise Value -1883085
Price to Sales(TTM) 10.3
Enterprise Value to Revenue 22.15
Enterprise Value to EBITDA -1.24
Shares Outstanding 6596560
Shares Floating 5086219
Shares Outstanding 6596560
Shares Floating 5086219
Percent Insiders 17.33
Percent Institutions 13.84

Analyst Ratings

Rating 4
Target Price 30
Buy 1
Strong Buy -
Buy 1
Strong Buy -
Hold -
Sell -
Strong Sell -
Strong Sell -

ai summary icon Upturn AI SWOT

Movano Inc

stock logo

Company Overview

overview logo History and Background

Movano Inc. was founded in 2018. It focuses on developing non-invasive wearable solutions to continuously monitor glucose and other health metrics. They have been actively working towards FDA clearance for their technologies.

business area logo Core Business Areas

  • Health Monitoring Devices: Development of wearable devices for continuous health monitoring, primarily focused on non-invasive glucose monitoring and other vital signs.
  • Data Analytics Platform: Development of a platform to collect, analyze, and present health data to users and healthcare providers.

leadership logo Leadership and Structure

The leadership team consists of key executives in technology, healthcare, and business. They operate under a traditional corporate structure with departments focusing on R&D, marketing, and operations.

Top Products and Market Share

overview logo Key Offerings

  • Evie Ring: Movano's lead product is the Evie Ring, a smart ring designed for women. It is designed to measure vital signs and other health metrics. It is currently awaiting FDA approval for certain health tracking features. The smart ring market is competitive, with players like Oura and Circular offering similar products.

Market Dynamics

industry overview logo Industry Overview

The wearable health technology market is experiencing rapid growth driven by increased consumer interest in personal health monitoring and advancements in sensor technology. The market is highly competitive with numerous established players and emerging startups.

Positioning

Movano Inc. is positioned as an innovator in the wearable health technology space, with a focus on non-invasive glucose monitoring and women's health. Their Evie Ring is aimed at disrupting the market by providing stylish and data rich information. The accuracy of their sensors will ultimately determine success.

Total Addressable Market (TAM)

The TAM for wearable health technology is estimated to be in the tens of billions of dollars and expected to grow further. Movano is positioned to capture a portion of this market through innovative devices and features.

Upturn SWOT Analysis

Strengths

  • Innovative technology
  • Focus on women's health
  • Potential for non-invasive glucose monitoring

Weaknesses

  • Reliance on successful product development and FDA clearance
  • Limited market presence compared to established competitors
  • Negative earning per share (EPS)

Opportunities

  • Partnerships with healthcare providers
  • Expansion into new health monitoring areas
  • Growing demand for wearable health technology

Threats

  • Competition from established players
  • Regulatory hurdles
  • Technological obsolescence

Competitors and Market Share

competitor logo Key Competitors

  • FIT
  • AAPL
  • ONEM

Competitive Landscape

Movano Inc. faces stiff competition from established players with significant market share and resources. The company's success hinges on differentiating itself through innovative technology and a strong brand.

Major Acquisitions

Growth Trajectory and Initiatives

Historical Growth: Movano Inc.'s historical growth is characterized by product development and preclinical testing, with minimal revenue to date.

Future Projections: Future growth depends heavily on the successful commercialization of their products, regulatory approvals, and market adoption. Analysts' estimates vary widely due to the high uncertainty.

Recent Initiatives: Recent initiatives include ongoing clinical trials, product development efforts, and preparations for regulatory submissions.

Summary

Movano is a speculative investment due to its early stage and dependence on technological breakthroughs and regulatory approvals. The company's focus on women's health and non-invasive monitoring presents potential, but significant risks remain due to stiff competition and high cash burn. Successful FDA clearance and market acceptance of their products are crucial for long-term viability. The company needs to maintain a solid cash runway and navigate the regulatory landscape to succeed.

Similar Companies

AAPLratingrating

Apple Inc

$229.86
Large-Cap Stock
0%
PASS

AAPLratingrating

Apple Inc

$229.86
Large-Cap Stock
0%
PASS

Sources and Disclaimers

Data Sources:

  • SEC Filings
  • Company Website
  • Analyst Reports

Disclaimers:

The information provided is for informational purposes only and should not be considered financial advice. Investment decisions should be made based on individual risk tolerance and due diligence.

Upturn AI SummarizationUpturn AI Summarization AI Summarization is directionally correct and might not be accurate.

Upturn AI SummarizationUpturn AI Summarization Summarized information shown could be a few years old and not current.

Upturn AI SummarizationUpturn AI Summarization Fundamental Rating based on AI could be based on old data.

Upturn AI SummarizationUpturn AI Summarization AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.

About Movano Inc

Exchange NASDAQ
Headquaters Pleasanton, CA, United States
IPO Launch date 1999-08-05
CEO, President & Director Dr. John Mastrototaro Ph.D.
Sector Healthcare
Industry Medical Devices
Full time employees 30
Full time employees 30

Movano Inc. engages in developing a platform to deliver healthcare solutions at the intersection of medical and consumer devices. The company is involved in the development of Evie Ring, which is a wearable designed specifically for women that combines health and wellness metrics comprises resting heart rate, heart rate variability (HRV), blood oxygen saturation (SpO2), respiration rate, skin temperature variability, period and ovulation tracking, and menstrual symptom tracking, as well as activity profile, including steps, active minutes and calories burned, sleep stages and duration, and mood tracking. It develops System-on-a-Chip (SoC) for blood pressure or continuous glucose monitoring (CGM) systems. The company was formerly known as Maestro Sensors Inc. and changed its name to Movano Inc. in August 2018. Movano Inc. was incorporated in 2018 and is based in Pleasanton, California.

Upturn is now on iOS and Android!

Experience Upturn on your mobile. Install it now!​